Literature DB >> 22465294

Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.

Pasquale Santangeli1, Antonio Dello Russo, Maurizio Pieroni, Michela Casella, Luigi Di Biase, J David Burkhardt, Javier Sanchez, Dhanunjaya Lakkireddy, Corrado Carbucicchio, Martina Zucchetti, Gemma Pelargonio, Sakis Themistoclakis, Antonia Camporeale, Antonio Rossillo, Salwa Beheiry, Richard Hongo, Fulvio Bellocci, Claudio Tondo, Andrea Natale.   

Abstract

BACKGROUND: Islets of myocytes within fibrofatty scars represent the substrate for reentrant ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC). Electroanatomic mapping can reliably identify such areas.
OBJECTIVE: To prospectively test the association between late and fragmented electrograms within scar and arrhythmic events in patients with ARVC.
METHODS: High-density right ventricle electroanatomic mapping was performed in 32 patients with ARVC without history of cardiac arrest or sustained ventricular arrhythmias. Standard definitions of electroanatomic scars and fragmented, isolated, and very late potentials were used. All patients received an implantable cardioverter-defibrillator for the primary prevention of sudden death.
RESULTS: After a mean follow-up of 25 ± 7 months, 12 (38%) patients received appropriate implantable cardioverter-defibrillator shock for sustained ventricular arrhythmias. With the exception of a higher rate of previous syncope (P = .053), patients with arrhythmic events at follow-up did not differ from those who remained free from arrhythmic events in terms of other clinical variables, including cardiac magnetic resonance findings. Electroanatomic scars were present in all patients. The distribution and extent of electroanatomic scars were similar in the 2 groups (38 ± 25 cm(2) vs 33 ± 20 cm(2); P = .51). However, patients with implantable cardioverter-defibrillator shock had a higher prevalence of fragmented electrograms (92% vs 20%; P <.001), of isolated late potentials (75% vs 20%; P = .004), and of very late potentials (67% vs 25%; P = .030). Fragmented electrograms were the only variable independently associated with arrhythmic events at follow-up (hazard ratio 21; P = .015).
CONCLUSION: The presence of fragmented and delayed electrograms within the scar predicts arrhythmic events in ARVC.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22465294     DOI: 10.1016/j.hrthm.2012.03.057

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  12 in total

1.  Remote magnetic navigation for ventricular ablation: did the machine win this round?

Authors:  J David Burkhardt
Journal:  J Interv Card Electrophysiol       Date:  2016-10-08       Impact factor: 1.900

2.  Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.

Authors:  Lauren Eberly; Lohit Garg; Mahesh Vidula; Nosheen Reza; Sheela Krishnan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-09-18

Review 3.  Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.

Authors:  Alessandro Zorzi; Ilaria Rigato; Barbara Bauce; Kalliopi Pilichou; Cristina Basso; Gaetano Thiene; Sabino Iliceto; Domenico Corrado
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 4.  Noncoding RNAs and myocardial fibrosis.

Authors:  Thomas Thum
Journal:  Nat Rev Cardiol       Date:  2014-09-09       Impact factor: 32.419

Review 5.  Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue.

Authors:  Angela Serena Maione; Chiara Assunta Pilato; Michela Casella; Alessio Gasperetti; Ilaria Stadiotti; Giulio Pompilio; Elena Sommariva
Journal:  Front Physiol       Date:  2020-04-03       Impact factor: 4.566

6.  Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis.

Authors:  Domenico Corrado; Peter J van Tintelen; William J McKenna; Richard N W Hauer; Aris Anastastakis; Angeliki Asimaki; Cristina Basso; Barbara Bauce; Corinna Brunckhorst; Chiara Bucciarelli-Ducci; Firat Duru; Perry Elliott; Robert M Hamilton; Kristina H Haugaa; Cynthia A James; Daniel Judge; Mark S Link; Francis E Marchlinski; Andrea Mazzanti; Luisa Mestroni; Antonis Pantazis; Antonio Pelliccia; Martina Perazzolo Marra; Kalliopi Pilichou; Pyotr G A Platonov; Alexandros Protonotarios; Alessandra Rampazzo; Jeffry E Saffitz; Ardan M Saguner; Christian Schmied; Sanjay Sharma; Hari Tandri; Anneline S J M Te Riele; Gaetano Thiene; Adalena Tsatsopoulou; Wojciech Zareba; Alessandro Zorzi; Thomas Wichter; Frank I Marcus; Hugh Calkins
Journal:  Eur Heart J       Date:  2020-04-07       Impact factor: 29.983

7.  Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.

Authors:  Paloma Jordà; Laurens P Bosman; Alessio Gasperetti; Andrea Mazzanti; Jean Baptiste Gourraud; Brianna Davies; Tanja Charlotte Frederiksen; Zoraida Moreno Weidmann; Andrea Di Marco; Jason D Roberts; Ciorsti MacIntyre; Colette Seifer; Antoine Delinière; Wael Alqarawi; Deni Kukavica; Damien Minois; Alessandro Trancuccio; Marine Arnaud; Mattia Targetti; Annamaria Martino; Giada Oliviero; Daniel C Pipilas; Corrado Carbucicchio; Paolo Compagnucci; Antonio Dello Russo; Iacopo Olivotto; Leonardo Calò; Steven A Lubitz; Michael J Cutler; Philippe Chevalier; Elena Arbelo; Silvia Giuliana Priori; Jeffrey S Healey; Hugh Calkins; Michela Casella; Henrik Kjærulf Jensen; Claudio Tondo; Rafik Tadros; Cynthia A James; Andrew D Krahn; Julia Cadrin-Tourigny
Journal:  Eur Heart J       Date:  2022-08-21       Impact factor: 35.855

8.  Relationship between MDCT-imaged myocardial fat and ventricular tachycardia substrate in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Yuki Komatsu; Amir Jadidi; Frederic Sacher; Arnaud Denis; Matthew Daly; Nicolas Derval; Ashok Shah; Heiko Lehrmann; Chan-Il Park; Reinhold Weber; Thomas Arentz; Gregor Pache; Maxime Sermesant; Nicholas Ayache; Jatin Relan; Michel Montaudon; François Laurent; Mélèze Hocini; Michel Haïssaguerre; Pierre Jaïs; Hubert Cochet
Journal:  J Am Heart Assoc       Date:  2014-08-07       Impact factor: 5.501

9.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement.

Authors:  Domenico Corrado; Thomas Wichter; Mark S Link; Richard N W Hauer; Frank E Marchlinski; Aris Anastasakis; Barbara Bauce; Cristina Basso; Corinna Brunckhorst; Adalena Tsatsopoulou; Harikrishna Tandri; Matthias Paul; Christian Schmied; Antonio Pelliccia; Firat Duru; Nikos Protonotarios; Na Mark Estes; William J McKenna; Gaetano Thiene; Frank I Marcus; Hugh Calkins
Journal:  Circulation       Date:  2015-07-27       Impact factor: 29.690

Review 10.  Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement.

Authors:  Domenico Corrado; Thomas Wichter; Mark S Link; Richard Hauer; Frank Marchlinski; Aris Anastasakis; Barbara Bauce; Cristina Basso; Corinna Brunckhorst; Adalena Tsatsopoulou; Harikrishna Tandri; Matthias Paul; Christian Schmied; Antonio Pelliccia; Firat Duru; Nikos Protonotarios; N A Mark Estes; William J McKenna; Gaetano Thiene; Frank I Marcus; Hugh Calkins
Journal:  Eur Heart J       Date:  2015-07-27       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.